ARTBIO | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

2 January 2024

Bristol makes its radiopharma move

The group’s $4.1bn swoop for RayzeBio follows big deals from Novartis and Lilly.

Subscribe to ARTBIO